no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A manifesto on improving cancer care in conflict-impacted populations
|
Ghebreyesus, Tedros Adhanom |
|
|
404 |
10451 |
p. 427 |
article |
2 |
A novel treatment approach for atopic dermatitis
|
Brunner, Patrick M |
|
|
404 |
10451 |
p. 407-409 |
article |
3 |
Bridging gaps in vertical transmission of HIV, syphilis, and hepatitis B in India
|
Saleem, Sheikh Mohd |
|
|
404 |
10451 |
p. 428-429 |
article |
4 |
Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature
|
Wei, Feixue |
|
|
404 |
10451 |
p. 435-444 |
article |
5 |
Continuing challenges to health equity in Ireland
|
O’Neill, Desmond |
|
|
404 |
10451 |
p. 431 |
article |
6 |
Cough syncope and recurrent respiratory papillomatosis
|
Kim, Christine |
|
|
404 |
10451 |
p. 474-475 |
article |
7 |
Differentiating mortality risk of individual infants and children to improve survival: opportunity for impact
|
Berkley, James A |
|
|
404 |
10451 |
p. 492-494 |
article |
8 |
Digitising the ageing process with epigenetic clocks
|
Horvath, Steve |
|
|
404 |
10451 |
p. 423 |
article |
9 |
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials
|
Bissonnette, Robert |
|
|
404 |
10451 |
p. 461-473 |
article |
10 |
Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial
|
Jacobs, Jeremy W |
|
|
404 |
10451 |
p. 433 |
article |
11 |
Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial
|
Ma, Run-wei |
|
|
404 |
10451 |
p. 433-434 |
article |
12 |
Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial – Authors' reply
|
Al-Samkari, Hanny |
|
|
404 |
10451 |
p. 434 |
article |
13 |
Evelyn Fox Keller
|
Green, Andrew |
|
|
404 |
10451 |
p. 426 |
article |
14 |
Hajj 2024 heatwave: addressing health risks and safety
|
Nashwan, Abdulqadir J |
|
|
404 |
10451 |
p. 427-428 |
article |
15 |
Hands-on: a novel JAK inhibitor for the treatment of chronic hand eczema
|
Renert-Yuval, Yael |
|
|
404 |
10451 |
p. 409-411 |
article |
16 |
Inequity in sustainable health today
|
Garay, Juan |
|
|
404 |
10451 |
p. 429-430 |
article |
17 |
Inflammatory bowel disease has no borders: engaging patients as partners to deliver global, equitable and holistic health care
|
Lamb, Christopher A |
|
|
404 |
10451 |
p. 414-417 |
article |
18 |
Janine Mohamed: championing Indigenous health
|
Prasad, Aarathi |
|
|
404 |
10451 |
p. 422 |
article |
19 |
Medicalised female genital mutilation must stop
|
The Lancet, |
|
|
404 |
10451 |
p. 405 |
article |
20 |
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials
|
Silverberg, Jonathan I |
|
|
404 |
10451 |
p. 445-460 |
article |
21 |
Palliative care needs to adapt to counteract assisted suicide
|
Lorenzl, Stefan |
|
|
404 |
10451 |
p. 430-431 |
article |
22 |
Realigning the physical activity research agenda for population health, equity, and wellbeing
|
Ding, Ding |
|
|
404 |
10451 |
p. 411-414 |
article |
23 |
Renal cell carcinoma
|
Young, Matthew |
|
|
404 |
10451 |
p. 476-491 |
article |
24 |
Russian attacks impacting maternal and child health
|
Holt, Ed |
|
|
404 |
10451 |
p. 418-419 |
article |
25 |
Scrutinising Big Soda
|
Boseley, Sarah |
|
|
404 |
10451 |
p. 424-425 |
article |
26 |
The rational design of cervical cancer prevention strategies
|
Schiffman, Mark |
|
|
404 |
10451 |
p. 406-407 |
article |
27 |
The role of the clinical virologist in pandemic responses
|
Banatvala, Jangu E |
|
|
404 |
10451 |
p. 430 |
article |
28 |
Understanding pandemic risks: the WHO Pandemic Hub
|
Samarasekera, Udani |
|
|
404 |
10451 |
p. 420-421 |
article |
29 |
Waiting list models must account for departures before treatment
|
Wood, Richard M |
|
|
404 |
10451 |
p. 431-432 |
article |
30 |
Waiting list models must account for departures before treatment – Authors' reply
|
Shah, Syed Ahmar |
|
|
404 |
10451 |
p. 432-433 |
article |